Successful Management of Multidrug-Resistant &lt;i&gt;Pseudomonas              aeruginosa&lt;/i&gt; Pneumonia after Kidney Transplantation in a          Dog

Park, Kyung-Mee; Nam, Hyoungsik; Woo, Heung‐Myong

doi:10.1292/jvms.13-0194

Cited by 9 publications

(5 citation statements)

References 20 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Was found that strains of P. aeruginosa isolates are resistant to multiple drugs, suggesting that selective pressure created by the persistent and possibly inappropriate use of these antimicrobials in veterinary clinic practice is one of the determining factors for the emergence of resistance; reason that justifies the MIR greater than 0.5 in 80% of P. aeruginosa strains isolated in the study; these results are consistent with those reported by Kyung-Mee on 2013 (27).…”

Section: Discussionsupporting

confidence: 90%

“…Se encontró que las cepas de P. aeruginosa aisladas son resistentes a múltiples fármacos, lo que sugiere que la presión selectiva creada por el uso persistente y posiblemente inadecuado de estos antimicrobianos en la práctica clínica veterinaria, es uno de los factores determinantes para la aparición de la resistencia; por esta razón se justifica un MIR superior al 0,5 en el 80% de las cepas de P. aeruginosa aisladas en el estudio; estos resultados son consistentes con los reportados por Kyung-Mee en 2013 (27).…”

Section: Discussionunclassified

See 1 more Smart Citation

Pseudomonas aeruginosa: an emerging nosocomial trouble in veterinary

2015

View full text Add to dashboard Cite

Objective. The goal of this study was to evaluate the susceptibility pattern of isolates P. aeruginosa from veterinary clinical centers in Bogotá, D.C., to some commonly used antibiotics in clinical. Materials and methods. Bacteriological standard protocols were used for the isolation and identification of bacterial strains. To evaluate the antimicrobial susceptibility of the isolates, to commonly used antibiotics, was performed the Kirby-Bauer agar-disk diffusion method on Mueller-Hinton agar. Results. A total of 160 samples was taken from clinical specimens and the environment in different veterinary clinics. Out of these samples, 89 (55.6%) were gram-negative strains, of which ten strains of P. aeruginosa were isolated (11.2%). All strains were resistant to Cefazolin, Lincomycin, Cephalothin, Ampicillin, Clindamycin, Sulfamethoxazole-Trimethoprim and Chloramphenicol while some isolates exhibited either resistance or an intermediate response to Amikacin (30%), Gentamicin (30%), Tobramycin (10%), Ciprofloxacin (20%), Ceftazidime (30%), Erythromycin (100%), Tetracycline (100%), Imipenem (10%), Meropenem (90%) and Bacitracin (90%). Conclusions. The results demonstrate that the acquired antimicrobial resistances of P. aeruginosa strains depend on antibiotic protocols applied. As observed in human hospitals, Pseudomonas aeruginosa is acting as one of the multidrug-resistant microorganisms of veterinary clinical relevance.

show abstract

Section: Discussionsupporting

confidence: 90%

Section: Discussionunclassified

Pseudomonas aeruginosa: an emerging nosocomial trouble in veterinary

2015

View full text Add to dashboard Cite

show abstract

“…P. aeruginosa infections can be associated with immunosuppression in companion animals. Pneumonia in a dog post‐kidney transplant has been reported (Park et al, 2013) along with cancer treatment‐associated infections (Curran et al, 2021). Some dog breeds are more prone to particular infections, with one example being eye infections in the St. Bernard: P. aeruginosa was the most common Gram‐negative pathogen in that niche and breed, and the most common multidrug‐resistant (MDR) pathogen with 100% of isolates displaying resistance to more than seven different antimicrobials (Nadăș et al, 2021).…”

Section: Assessmentmentioning

confidence: 99%

Assessment of listing and categorisation of animal diseases within the framework of the Animal Health Law (Regulation (EU) No 2016/429): antimicrobial‐resistant Pseudomonas aeruginosa in dogs and cats

Nielsen¹,

Bicout²,

Calistri³

et al. 2022

EFS2

View full text Add to dashboard Cite

Pseudomonas aeruginosa (P. aeruginosa) was identified among the most relevant antimicrobial‐resistant (AMR) bacteria in the EU for dogs and cats in a previous scientific opinion. Thus, it has been assessed according to the criteria of the Animal Health Law (AHL), in particular criteria of Article 7 on disease profile and impacts, Article 5 on its eligibility to be listed, Annex IV for its categorisation according to disease prevention and control rules as in Article 9, and Article 8 for listing animal species related to the bacterium. The assessment has been performed following a methodology previously published. The outcome is the median of the probability ranges provided by the experts, which indicates whether each criterion is fulfilled (lower bound ≥ 66%) or not (upper bound ≤ 33%), or whether there is uncertainty about fulfilment. Reasoning points are reported for criteria with uncertain outcome. According to the assessment here performed, it is uncertain whether AMR P. aeruginosa can be considered eligible to be listed for Union intervention according to Article 5 of the AHL (33–90% probability). According to the criteria in Annex IV, for the purpose of categorisation related to the level of prevention and control as in Article 9 of the AHL, the AHAW Panel concluded that the bacterium does not meet the criteria in Sections 1, 2, 3 and 4 (Categories A, B, C and D; 0–5%, 1–5%, 5–33% and 5–33% probability of meeting the criteria, respectively) and the AHAW Panel was uncertain whether it meets the criteria in Section 5 (Category E, 33–90% probability of meeting the criteria). The animal species to be listed for AMR P. aeruginosa according to Article 8 criteria are mainly dogs and cats.

show abstract

“…Sadece birkaç antibiyotik Pseudomonas'lara karşı etkilidir ki bunlar, flourokinolonlar, gentamisin ve imipenem'dir. Yine de bunların herbiri tüm serotiplere karşı etkili değildir [19,24]. Köpeklerde P. aeruginosa ile ilişkili bronşiektazi enfeksiyonlarında, amoksisilin klavulanik asit kombinasyonu hariç betalaktamlar uygun seçim değildir çünkü solunum yollarına penetrasyonları zayıftır.…”

Section: Tartışma Ve Sonuçunclassified

Köpeklerde Burun Boşluğundan Pseudomonas aeruginosa’nın İzolasyonu ve Antibiyotik Duyarlılıkları

Zeyrek

Erbaş

2019

Etlik Veteriner Mikrobiyoloji Dergisi

View full text Add to dashboard Cite

Pseudomonas aeruginosa inatçı bir patojendir ve antibiyotik dirençliliği nedeniyle de mücadelesi zordur. Araştırmamızda Aydın'ın Kuşadası ilçesinde bulunan özel bir Veteriner kliniğine 2017 yılı Ekim-Kasım-Aralık aylarında gelen köpeklerin burun boşluğundan alınan 100 adet sürüntü örneği P. aeruginosa yönünden incelenmiştir. Örnekler alındıktan sonra soğuk zincir altında Aydın Adnan Menderes Üniversitesi Veteriner Fakültesi Mikrobiyoloji Rutin Teşhis laboratuarına getirilmişlerdir. Yapılan mikrobiyoloji analizler neticesinde 11 adet P. aureginosa izole ve identifiye edilmiş ve izolatların Kirby Bauer disk difüzyon yöntemi ile antibiyotik duyarlılıkları belirlenmiştir. P. aeruginosa izolatlarının tamamı Amoksisilin klavulonik asit, Ampisilin/sulbaktam, İmipemen , Kloksasilin ve Penisilin/ Novobiosin'e karşı dirençli oldukları tespit edilmiştir. Kanamisin/Cephaleksin'e karşı izolatlardan 7'sinin dirençli (%64), 4'ünün ise duyarlı (%36) olduğu belirlenmiştir. Bununla birlikte 5 izolatın Oksitetrasiklin'e orta düzey duyarlı (%45), 6 izolatın ise duyarlı (%55) olduğu belirlenmiştir. Çalışmada elde edilen 11 izolatın tümünün Enrofloksasin ve Gentamisin'e karşı duyarlı olduğu saptanmıştır. Köpeklerde solunum yolunu etkileyen bakteriyel hastalıklarda etkenin identifikasyonu ve doğru antibiyotik seçimi oldukça önemlidir. Çalışma sonuçları P. aureginosa izolatlarının çoklu antibiyotik direncine sahip olduklarını göstermiştir. Bununla birlikte klinik olarak karşılaşılabilecek vakalarda tedavide Enrofloksasin ve/veya Gentamisin etken maddeleri tavsiye edilmektedir.

show abstract

Successful Management of Multidrug-Resistant <i>Pseudomonas aeruginosa</i> Pneumonia after Kidney Transplantation in a Dog

Cited by 9 publications

References 20 publications

Pseudomonas aeruginosa: an emerging nosocomial trouble in veterinary

Pseudomonas aeruginosa: an emerging nosocomial trouble in veterinary

Assessment of listing and categorisation of animal diseases within the framework of the Animal Health Law (Regulation (EU) No 2016/429): antimicrobial‐resistant Pseudomonas aeruginosa in dogs and cats

Köpeklerde Burun Boşluğundan Pseudomonas aeruginosa’nın İzolasyonu ve Antibiyotik Duyarlılıkları

Contact Info

Product

Resources

About